FR7702M - - Google Patents

Info

Publication number
FR7702M
FR7702M FR159715A FR159715A FR7702M FR 7702 M FR7702 M FR 7702M FR 159715 A FR159715 A FR 159715A FR 159715 A FR159715 A FR 159715A FR 7702 M FR7702 M FR 7702M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR159715A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR159715A priority Critical patent/FR7702M/fr
Application granted granted Critical
Publication of FR7702M publication Critical patent/FR7702M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR159715A 1968-07-18 1968-07-18 Expired FR7702M (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR159715A FR7702M (enExample) 1968-07-18 1968-07-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR159715A FR7702M (enExample) 1968-07-18 1968-07-18

Publications (1)

Publication Number Publication Date
FR7702M true FR7702M (enExample) 1970-02-23

Family

ID=8652754

Family Applications (1)

Application Number Title Priority Date Filing Date
FR159715A Expired FR7702M (enExample) 1968-07-18 1968-07-18

Country Status (1)

Country Link
FR (1) FR7702M (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024623A3 (en) * 2000-09-22 2003-02-20 Glaxo Group Ltd Novel alkanoic acid derivatives
WO2011003870A3 (en) * 2009-07-06 2011-03-31 Creabilis S.A. Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
WO2024037644A1 (zh) * 2022-08-19 2024-02-22 津药生物科技(天津)有限公司 Peg修饰的糖皮质激素药物及其用途

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024623A3 (en) * 2000-09-22 2003-02-20 Glaxo Group Ltd Novel alkanoic acid derivatives
WO2011003870A3 (en) * 2009-07-06 2011-03-31 Creabilis S.A. Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
WO2024037644A1 (zh) * 2022-08-19 2024-02-22 津药生物科技(天津)有限公司 Peg修饰的糖皮质激素药物及其用途

Similar Documents

Publication Publication Date Title
AU5506869A (enExample)
AU5184069A (enExample)
JPS528308B1 (enExample)
AU6168869A (enExample)
FR7604M (enExample)
AU6171569A (enExample)
FR7702M (enExample)
AU416157B2 (enExample)
AU4811568A (enExample)
AU4744468A (enExample)
BE709479A (enExample)
BE709446A (enExample)
BE709435A (enExample)
BE709415A (enExample)
BE709320A (enExample)
BE709319A (enExample)
BE709496A (enExample)
BE709301A (enExample)
BE709274A (enExample)
BE709138A (enExample)
BE721276A (enExample)
BE709119A (enExample)
BE709095A (enExample)
BE708951A (enExample)
BE709484A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse